NCT05413850 2026-04-13Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionBlue Earth Therapeutics LtdPhase 1/2 Recruiting82 enrolled
NCT07038369 2026-03-17A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsAtavistik Bio, IncPhase 1 Active not recruiting134 enrolled
NCT06681233 2026-03-13Feasibility Study of CBCT for IGRT in Cancer PatientsVarian, a Siemens Healthineers CompanyPhase NA Recruiting50 enrolled